RECORD // Company

Candel Therapeutics, Inc.

Built 2026-11-22T00:00:42Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (3)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Candel Therapeutics, Inc. · Ctgov · same registered legal name as 'Candel Therapeutics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CANDEL THERAPEUTICS · Epa echo · exact name match to 'Candel Therapeutics, Inc.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • CANDEL THERAPEUTICS, INC. · USAspending · same registered legal name as 'Candel Therapeutics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

6 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001193125-26-458380

ItemValuePeriodFormFiledAccessionReport
Net income (loss)$-21,873,0003 months ended 2026-09-3010-Q2026-11-120001193125-26-4583802026-11-22 00:00 UTCReport an error
Interest expense$1,591,0003 months ended 2026-09-3010-Q2026-11-120001193125-26-4583802026-11-22 00:00 UTCReport an error
Cash and cash equivalents$203,116,000at 2026-09-3010-Q2026-11-120001193125-26-4583802026-11-22 00:00 UTCReport an error
Debt due in year 2$3,797,000at 2026-09-3010-Q2026-11-120001193125-26-4583802026-11-22 00:00 UTCReport an error
Debt due in year 3$24,154,000at 2026-09-3010-Q2026-11-120001193125-26-4583802026-11-22 00:00 UTCReport an error
Debt due in year 4$22,049,000at 2026-09-3010-Q2026-11-120001193125-26-4583802026-11-22 00:00 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Revenue.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001841387
Ticker
CADL
EIN
522214851
CUSIP
137404109
Record ID
sx:sec:0001841387

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

26 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 00:00 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-16SEC EDGAR company profile2026-11-22 00:00 UTCReport an error
State of incorporationDE2026-11-16SEC EDGAR company profile2026-11-22 00:00 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 00:00 UTCReport an error
Business address117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 024942026-11-16SEC EDGAR company profile2026-11-22 00:00 UTCReport an error
ExchangesNasdaq2026-11-16SEC EDGAR company profile2026-11-22 00:00 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-38,182,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 00:00 UTCReport an error
Total assets (at 2025-12-31)$125,195,0002025-12-3110-K, XBRL Assets2026-11-22 00:00 UTCReport an error
Stockholders' equity (at 2025-12-31)$51,922,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 00:00 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$119,731,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:00 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-38,311,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:00 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$587,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:00 UTCReport an error
Long-term debt (at 2024-12-31)$1,733,0002024-12-3110-K, XBRL LongTermDebtNoncurrent2026-11-22 00:00 UTCReport an error
Operating lease liabilities (at 2025-12-31)$1,904,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 00:00 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-12)On November 12, 2026, Candel Therapeutics, Inc. announced its financial results for the quarter ended September 30, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is furnished herewith and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act…2026-11-12SEC EDGAR 8-K 0001193125-26-458316 (text as filed, excerpt)2026-11-22 00:00 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-09-10)On September 10, 2026, the Company issued a press release titled “Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors.” A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated herein by reference. The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K are furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be incorporated by reference into any filing under the…2026-09-10SEC EDGAR 8-K 0001193125-26-387310 (text as filed, excerpt)2026-11-22 00:00 UTCReport an error
Largest institutional holder #1 (13F as filed): FMR LLC$113,202,5102026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:00 UTCReport an error
Largest institutional holder #2 (13F as filed): RTW INVESTMENTS, LP$66,146,7852026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:00 UTCReport an error
Largest institutional holder #3 (13F as filed): BlackRock, Inc.$51,181,1122026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:00 UTCReport an error
Largest institutional holder #4 (13F as filed): STATE STREET CORP$36,563,1772026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:00 UTCReport an error
Largest institutional holder #5 (13F as filed): ACORN CAPITAL ADVISORS, LLC$36,028,8642026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:00 UTCReport an error
Largest institutional holder #6 (13F as filed): Portolan Capital Management, LLC$35,951,0992026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:00 UTCReport an error
Largest institutional holder #7 (13F as filed): Saturn V Capital Management LP$34,027,9662026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:00 UTCReport an error
Largest institutional holder #8 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$27,748,6122026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:00 UTCReport an error
Largest institutional holder #9 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$16,183,8842026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:00 UTCReport an error
Largest institutional holder #10 (13F as filed): MILLENNIUM MANAGEMENT LLC$11,267,2222026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:00 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.